The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Bactrim DS (bactrim DS DS tablet) is a combination of two drugs:
Fluoroquinolone
Bactrim DS (bactrim DS) (brand name: Septra DS, generic name: Septra) is a combination of two drugs:
Bactrim DS is used to treat infections caused by certain bacteria and certain parasites in various parts of the body. The bacteria are responsible for:
Infections of the lungs, throat, nose, genital area, and vagina
Bacterial pneumonia
Urinary tract infections (UTIs)
Respiratory tract infections
Sexually transmitted infections (STIs)
Bactrim DS is not indicated for use in children younger than 6 months of age.
The content on this page has been supplied to canadianpharmacyworld.com by an independent third party contracted to provide information for our website. Canadianpharmacyworld.com relies on these third parties to create and maintain this information and cannot guarantee the accuracy or reliability of the information that has been provided to us.
The drug information provided here is only a summary and does not contain all the list of possible side effects and drug interactions regarding this medication. Be sure to contact your doctor or pharmacist if you have any specific question or concern. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a healthcare professional.
Additional Information:Please note: Pharmacies and CIPA/IPS (Additional Information Platforms Used by Pharmacists and Patients) are governed by the laws of the destination country and all cookies will be made in accordance with the provider's terms and conditions. If you have specific questions about the drugs on this page, you can contact the pharmacy or CIPA by emailing.
Copyright © 2013 Canadianpharmacyworld.com. All Rights Reserved.UPC:
96122903The content on this page has been provided by Canadianpharmacyworld.com an independent third party and is not intended to be used to represent any drug company. Canadianpharmacyworld.com assumes no liability for untrue about or representations about the content provided by Canadianpharmacyworld.com.
A study published inThe Journal of Pediatric Infection(JIPID) found that antibiotics prescribed to children under 12 with urinary tract infection, such as bactrim, were associated with significantly higher rates of antimicrobial resistance (AMR). The researchers hypothesized that antimicrobials may have an important role in treating infections in children.
“To the best of our knowledge, this is the first study to examine the use of antibiotics in children under 12, and their role in treatment of urinary tract infection in children,” Dr. David R. Shulman, a leading pediatric infectious disease specialist at the University of Florida School of Medicine, and colleagues, reported in the JIPID journal. “The findings of the study highlight the importance of using antibiotics in children under 12 and the development of new treatment options for urinary tract infection in children.”
The study included a sample of more than 1,000 children, ages 2 to 17, who were hospitalized at a pediatric hospital from April to July 2019. The researchers examined all of the data from the outpatient and inpatient cases. “We also looked at AMR rates, as well as antibiotic resistance and bacterial resistance patterns,” Dr. Shulman said. “In particular, we focused on the antibiotics used to treat UTIs, the first and most common type of UTI, and the most common form of bacterial resistance.”
For the purposes of this study, the researchers included a total of 809 children who had been hospitalized in a pediatric hospital and were treated with antibiotics from the previous month. All the children had been hospitalized for at least three days. The antibiotics used in this study were trimethoprim (Trimethoprim-Sulfa), tetracycline, doxycycline, ceftriaxone, amoxicillin, azithromycin, and clindamycin. The researchers also assessed AMR rates among the patients. “The researchers found that the antibiotics used to treat UTIs, the first and most common type of UTI, and the most common form of bacterial resistance were not associated with an increased AMR,” Dr. Shulman noted. “The authors note that while this study suggests that antibiotics may play a role in treating UTI in children, this is the first study to examine the use of antibiotics in children and to examine the antibiotic resistance patterns in children.”
The researchers analyzed the antibiotic susceptibility patterns of all patients from the last two months of 2019, which is included in the JIPID study. “The antibiotic resistance patterns and the antimicrobial resistance rates are consistent across all three antibiotics used in this study,” Dr. “It is important to note that while the antibiotic resistance patterns across all three antibiotics used in this study are consistent across all patients,” Dr. Shulman added. “This study suggests that while antibiotics may play a role in treating UTI in children, the use of antibiotics in these children is not a one-off phenomenon.”
The researchers also analyzed the antibiotic resistance patterns in patients with any UTI. “Using a broad-spectrum antibiotic, we found that the use of trimethoprim-sulfa and tetracycline was not associated with an increased risk of AMR,” Dr. “The researchers note that while the use of trimethoprim-sulfa and tetracycline is associated with an increased risk of AMR in children, this is the first study to investigate the use of antibiotics in children.”
“Antibiotic resistance patterns in the antibiotic-resistant UTI population is well established,” Dr. “In our study, we observed a significant increase in resistance to the antibiotic ciprofloxacin among the patients with UTIs who used trimethoprim-sulfa and tetracycline for more than three days, compared to the patients who used trimethoprim-sulfa and tetracycline only. This indicates that the use of trimethoprim-sulfa and tetracycline is associated with an increased risk of antibiotic resistance, which may be useful in the future.”
The researchers also analyzed the antimicrobial resistance patterns in patients with any UTI. “The results indicate that while the use of trimethoprim-sulfa and tetracycline may be associated with an increased risk of AMR in children, the use of trimethoprim-sulfa and tetracycline is not associated with an increased risk of AMR,” Dr.
Bactrim DS: How It Works
is a combination of two medications, sulfamethoxazole and trimethoprim, that work together to inhibit the growth of bacteria by interfering with the production of the bacterial cell wall. Sulfamethoxazole is commonly prescribed as an antibiotic, while trimethoprim is a prodrug that is used to treat a range of bacterial infections. Bactrim DS works by inhibiting the synthesis of bacterial cell walls, thereby interfering with the bacteria's ability to produce proteins and DNA.
The effectiveness of Bactrim DS is attributed to its ability to work by targeting specific bacteria, which can then bind to the bacterial cell wall and form complexes with proteins to disrupt its growth. This disruption can lead to bacterial overgrowth and ultimately kill the infection causing bacteria. In contrast, the effectiveness of trimethoprim is attributed to its ability to inhibit the production of a broad spectrum antibiotic, which can then bind to the bacteria's surface, which allows the bacteria to produce multiple antibiotics without causing them to develop resistance.
Understanding how Bactrim DS functions is crucial in ensuring its effectiveness and minimizing potential adverse effects. By blocking the synthesis of bacterial cell walls, it provides a targeted approach to bacterial infections. By inhibiting bacterial growth, Bactrim DS provides a reliable and effective antibiotic that targets the bacterial cell wall, potentially leading to less resistant bacteria. This targeted approach ensures that Bactrim DS effectively targets the underlying infection, allowing individuals to recover from their infections with minimal discomfort.
Bactrim DS Side Effects
Like any medication, Bactrim DS may cause side effects. Common side effects of Bactrim DS can include nausea, diarrhea, vomiting, dizziness, and headache. These side effects are usually mild and temporary, but they can be severe and may require medical attention. If you experience any severe or persistent side effects while taking Bactrim DS, contact your healthcare provider immediately.
Bactrim DS Precautions
Before using Bactrim DS, it's essential to consult with a healthcare professional to determine if it's appropriate for your condition and to ensure that it's the right medication for your specific needs. Bactrim DS is available in tablet form, which is why it is commonly prescribed as an antibiotic. It is important to follow your healthcare provider's instructions when taking Bactrim DS, as some of the side effects may be mild and temporary. Additionally, Bactrim DS should not be taken with antibiotics or other antifungal medications, as these can interfere with the effectiveness of the medication. Additionally, taking Bactrim DS with food can increase the risk of gastrointestinal upset. Additionally, Bactrim DS should not be taken with dairy products, as dairy products can affect the absorption of this antibiotic and may interfere with its effectiveness. It's essential to adhere to the prescribed dosage and frequency of use to avoid potential side effects. Consulting with a healthcare provider before beginning treatment can help ensure that the benefits of Bactrim DS are fully understood and understood.
Common side effects of Bactrim DS can include nausea, diarrhea, vomiting, headache, and abdominal pain. These side effects are usually mild and temporary, but they can be severe and require medical attention. If you experience severe or persistent side effects while taking Bactrim DS, contact your healthcare provider immediately. In some cases, more severe side effects may occur, such as tendonitis or tendon rupture. In rare cases, more serious side effects may occur, such as bone pain, hearing loss, or severe allergic reactions. It's essential to follow the prescribed dosage and duration of treatment to monitor any potential side effects. It's also important to complete the full course of Bactrim DS unless instructed by your healthcare provider to stop taking the medication. Regular follow-ups are essential to monitor progress and adjust the treatment plan as necessary. By following these guidelines, you can minimize the risk of side effects while taking Bactrim DS, and ensure that you receive the right treatment for your condition.
Bactrim DS can be taken with or without food.
Salt Composition in both
Sulfamethoxazole 800mg + Trimethoprim 160mg
Salt Composition
(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Co Trimoxazole DS 800/160mg Tablet 10s
1,696+ Customers trust this
WHO GMP Certified
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
New productTrimoxazoleis a β-N-ethinyl-6-oxo-5-naphthylaminopyrimidinyl-1(1,4-benzodioxol-5-yl) pyrimidinyl-1(1,4)-thione. It belongs to the class of antineoplastic drugs and works by slowing down the growth and spread of cancer cells. Trimoxazole slows down the progression of certain types of cancer by inhibiting the growth and spread of malignant cells.
$8.95
Treats breast cancer in postmenopausal women. This medicine is also effective in treating benign prostatic hyperplasia.
Common side effects include drowsiness, dry mouth, fatigue, headache, nausea, and dizziness.